These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17235406)

  • 1. [Decrease in bactericidal activity of ciprofloxacin in Salmonella mutants generated following repeated exposure to various fluorquinolones].
    Cebrián L; Rodríguez JC; Escribano I; Ruiz M; Royo G
    Rev Esp Quimioter; 2006 Dec; 19(4):363-6. PubMed ID: 17235406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
    Cebríán L; Rodríguez JC; Escribiano I; Royo SG
    APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the gyrA and parC genes in Salmonella spp. following in vitro exposure to fluoroquinolones.
    Cebrian L; Escribano I; Rodriguez JC; Royo G
    J Chemother; 2006 Jun; 18(3):250-4. PubMed ID: 17129834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica.
    Randall LP; Cooles SW; Piddock LJ; Woodward MJ
    J Antimicrob Chemother; 2004 Sep; 54(3):688-91. PubMed ID: 15243029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
    Escribano I; Rodríguez JC; Royo G
    Int J Antimicrob Agents; 2004 Sep; 24(3):300-3. PubMed ID: 15325438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
    Cebrián L; Rodríguez JC; Escribano I; Royo G
    Chemotherapy; 2005 Mar; 51(1):40-3. PubMed ID: 15767744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
    Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP
    Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.
    Sierra JM; Cabeza JG; Ruiz Chaler M; Montero T; Hernandez J; Mensa J; Llagostera M; Vila J
    Clin Microbiol Infect; 2005 Sep; 11(9):750-8. PubMed ID: 16104991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp.
    Cebrian L; Rodríguez JC; Escribano I; Royo G
    APMIS; 2006; 114(7-8):523-8. PubMed ID: 16907858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones.
    Cebrian L; Sirvent E; Rodríguez Díaz JC; Ruiz M; Royo G
    Int J Antimicrob Agents; 2003 Aug; 22(2):134-9. PubMed ID: 12927953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    FEMS Microbiol Lett; 2004 Sep; 238(1):267-72. PubMed ID: 15336432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
    Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204.
    Baucheron S; Chaslus-Dancla E; Cloeckaert A
    J Antimicrob Chemother; 2004 Apr; 53(4):657-9. PubMed ID: 14985270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
    Preisler A; Mraheil MA; Heisig P
    J Antimicrob Chemother; 2006 Mar; 57(3):430-6. PubMed ID: 16431864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.